Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial.
Laura JanssenMariëlle Romberg-CampsAd van BodegravenJeoffrey HaansMichèl AquariusPaul BoekemaTamara MunnecomLloyd BrandtsManuela JooreAdrian MascleeD JonkersM PierikPublished in: BMJ open (2021)
NCT03917303.
Keyphrases